Recorded webinars

HMB: It’s time to talk, time to act? (Case 1 & 2)

HMB: It’s time to talk, time to act? (Case 1 & 2)

Case 1 - Lottie Case 2 - Josie

Description

We have re-purposed the content within from the live webinar to create these on demand cases.

 

  • Case 1 - Lottie
  • 16 year old patient presents to your clinic with heavy menstrual bleeding. Previously she has had multiple hospital admissions requiring blood transfusions and is known to suffer from Von Willebrand’s Disease.
    Learning objectives:
    • Prevalence of heavy menstrual bleeding in patients with bleeding disorders
    • Treatment options available for HMB in patient’s with known bleeding disorders
    • How to counsel younger patients on available treatment options for heavy menstrual bleeding
       
  • Case 2 - Josie
  • 22 year old patient takes combined oral contraceptive pill for heavy menstrual bleeding and period cramps. However she has problems with compliance and she had a medical abortion 8 weeks ago.
    Learning Objectives:
    • How to counsel patients with compliance issues and heavy menstrual bleeding
    • Treatment options for patients with heavy menstrual bleeding and pain

Speakers

Chair:

Dr Diana Mansour

 

Consultant in Community Gynaecology and Reproductive Health Care, FSRH Senior Vice President. Newcastle Hospitals, United Kingdom.

Dr Diana Mansour

Dr Diana Mansour is a Consultant in Community Gynaecology and Reproductive Health Care and has been an Associate Clinical Lecturer at the University of Newcastle since 1997. In addition, Dr Mansour is the Senior Vice President for the Faculty of Sexual and Reproductive Healthcare.

 

Dr Mansour was the first accredited subspecialty trainee in Community Gynaecology and Reproductive Health Care of the Royal College of Obstetricians and Gynaecologists. Dr Mansour is first author to over 90 peer-reviewed publications and has most recently published in Contraception and the BMJ SRH.

 

Dr Mansour’s areas of expertise include acceptability of contraceptive methods, non-contraceptive benefits of contraception, development of long-term methods of contraception, changes in health service provision, medical management of menstrual disorders and management of the menopause.

 

Panel:

Dr Anne Connolly

 

GPSI gynaecology, CCG Board lead for maternity, children and young people NHS Bradford

Dr Anne Connolly

Having survived a two year posting to a mission hospital in rural Zimbabwe, Anne returned to General Practice in inner-city Bradford in 1990 and is currently working as a GP providing care for asylum seekers, refugees, homeless populations and sex workers.

 

She is a GPSI in gynaecology, accredited as a hysteroscopist and FSRH trainer. She has been involved with commissioning since 2006 with remit for maternity, women’s, children and young people’s healthcare.

 

Anne is chair of the PCWHF and RCGP Clinical Champion for Women’s Health. She is also co-editor of Women’s Health in Primary Care.

 

Dr Aamena Salar

 

Medical Director Modality Community Services LLP
GP Partner Modality Partnerships
DRCOG, DFSRH, PG Dip Community Gynaecology, PG Cert Diagnostic Hysteroscopy

Dr Aamena Salar

Dr Salar developed an interest in Women’s Health as a GP registrar in Birmingham. She went on to complete the FSRH and DRCOG during her training and subsequently went on to complete Community Gynaecology Diploma and Diagnostic Hysteroscopy Diploma from Bradford University.

 

Dr Salar was given the opportunity to pilot a new Gynaecology service as part of the Vanguard 5 year Forward Plan project. 4 years on, that service is still running and commissioned via SWBH NHS Trust. The team has now expanded, and she has the opportunity to train other GPs and Nurses to join the team.

 

Reporting adverse events and quality complaints

Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard. Adverse events should also be reported to Bayer plc.

 

If you want to report an adverse event or quality complaint, reports can be directed to: Tel: 011820‍63500 or email: pvuk@bayer.com

 

Further information is available on the “contact” tab at www.bayer.co.uk.